Table 1. Criteria for differentiating acute and chronic hepatitis C

Slides:

Advertisements

Similar presentations

1 Survey Data in ECA : Frequency, Coverage, Consistency and Access By Victor Sulla ECS-PE.

Advertisements

Directive 95/50/EC TDG Checks Application of Annexes Erkki Laakso EUROPEAN COMMISSION DG ENERGY & TRANSPORT TDG Checks Riga June 2006.

Erasmus+ International Credit Mobility Call for Proposals 2016

Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.

Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Progress of European integration

Surveillance of hepatitis B and C in the EU/EEA

Surveillance Data reported by Case definition used characteristics

Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014

Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.

Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

DISTRIBUTION AUTOMATIC - GENERATION

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country

Country Cases Rate National data Report type

Table 1. Reported invasive Haemophilus influenzae cases: number and rate per population, EU/EEA, 2010–2014 Country Confirmed.

Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Country Cases Rate National data Report type

Table. Ebola and Marburg fevers, surveillance systems overview, 2014

Table 1. Criteria for differentiating acute and chronic hepatitis B

Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: number and rate per population, EU/EEA, 2010–2014 Country

Surveillance of hepatitis B and C in the EU/EEA – 2016 data

Country Cases Rate National data Report type

Cases Rate National data Report type

Table. Yellow fever, surveillance systems overview, 2014

Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,

Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country

Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

The European Parliament – voice of the people

The European Parliament – voice of the people

ESF FINANCIAL EXECUTION PART 1 STATE OF PLAY END 2016

Country Cases Rate National data Report type

Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2011–2015 Country

EU: First- & Second-Generation Immigrants

Table 1. Number of reported confirmed LGV cases, EU/EEA, 2010–2014

MSFD Scoreboard Status at 23 November 2012 Belgium Bulgaria Cyprus

Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Country Cases Rate National data Report type

Table 1. Number and rate of reported confirmed gonorrhoea cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.

Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.

Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014

Table 1. Number and rate of reported confirmed chlamydia cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.

Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018

Country Cases Rate National data Report type

Country Cases Rate National data Report type

Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.

European Union Membership

Table. Plague, surveillance systems overview, 2014

Chlamydia In 2016, cases of chlamydia infection were reported in 26 EU/EEA Member States. The overall notification rate was 184 per 100 000 persons.

Country Cases Rate Austria Belgium Bulgaria

Overall 2011 ESF Budget Execution

ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018

Surveillance of hepatitis B and C in the EU/EEA – 2016 data

Table 1. Locally acquired cases of West Nile fever: number and rate per population, EU/EEA, 2010–2014 Country Cases Rate.

Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,

ESF FINANCIAL EXECUTION ESF Technical Working Group Meeting June 2018

Country Cases Rate National data Report type

Source: Country reports

Trends for ECDC measles and rubella monitoring,

Country Cases Rate National data Report type

Marine Strategy Framework Directive: Status of reporting

Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Table 1. Table 1. Reported confirmed toxoplasmosis cases: number and rate per live births, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Source: Country reports

Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Presentation transcript:

Table 1. Criteria for differentiating acute and chronic hepatitis C Stage Definition Acute Recent HCV seroconversion (prior negative test for hepatitis C in last 12 months) or Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C virus core antigen (HCV-core) in serum/plasma and no detection of hepatitis C virus antibody (negative result) Chronic Detection of hepatitis C virus nucleic acid (HCV RNA) or hepatitis C core antigen (HCV-core) in serum/plasma in two samples taken at least 12 months apart* Unknown Any newly diagnosed case which cannot be classified in accordance with the above definition of acute or chronic infection Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Table 2. Number and rate of reported hepatitis C cases per 100 000 population, EU/EEA, 2010–2014† 2010 2011 2012 2013 2014 Country All Acute* Chronic* Unknown* Cases Rate Austria 880 10.5 1122 13.4 1075 12.8 993 11.7 1954 23 93 1.1 913 10.7 948 11.1 Belgium 1151 Bulgaria 58 0.8 60 92 1.3 95 90 1.2 Croatia 171 4 202 4.7 144 3.4 Cyprus 26 3.2 57 6.8 48 5.6 36 4.2 30 3.5 Czech Republic 709 812 7.7 796 7.6 929 8.8 808 Denmark 318 5.7 295 5.3 263 265 181 6 0.1 173 3.1 2 Estonia 276 20.7 210 15.8 245 18.5 273 315 23.9 20 1.5 22.4 Finland 1138 21.3 1135 21.1 1165 21.6 1172 1224 22.5 France Germany 5281 6.5 5075 6.2 4978 6.1 5168 6.3 5737 7.1 Greece 11 18 0.2 43 0.4 22 <0.1 16 Hungary 38 46 0.5 Iceland 59 18.6 72 22.6 51 Ireland 1240 27.3 1254 27.4 1026 778 16.9 694 15.1 21 68 605 13.1 Italy 236 234 221 205 0.3 45 Latvia 1156 54.5 1324 63.8 1352 66.1 1327 65.6 1491 74.5 2.8 1434 71.6 Lithuania 41 1.4 40 34 Luxembourg 73 14.5 74 53 10.1 12.7 12.4 Malta 14 4.3 24 3.3 1 13 Netherlands 31 65 52 Norway 1783 36.7 1675 1513 30.3 1318 26.1 1213 23.7 Poland 2179 2241 5.9 2265 2641 6.9 3551 9.3 Portugal 39 42 63 0.6 7 56 Romania 76 80 126 127 104 84 Slovakia 237 4.4 304 230 314 5.8 381 35 346 6.4 Slovenia 87 4.6 102 5 89 64 3 61 Spain Sweden 1939 20.8 2153 22.9 1990 2005 1786 United Kingdom 9951 15.9 12138 19.3 13474 21.2 13757 21.5 14028 21.8 1291 12737 19.8 Total EU/EEA 27849 7.3 30645 8 31480 8.1 32061 8.3 35321 458 4698 3.7 26380 9.5 † Data presented by date of diagnosis. * Includes the cases reported by countries as acute, chronic or unknown using the differentiation criteria Source: Country reports Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 1. Rate of acute and chronic hepatitis C cases per 100 000 population, EU/EEA, 2006–2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 2. Rate of reported acute hepatitis C cases per 100 000 population, EU/EEA, 2014 Source: Country reports from Austria, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 3. Rate of reported hepatitis C cases per 100 000 population, by age and gender, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Sweden, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Figure 4. Transmission category of hepatitis C cases by acute and chronic disease status, EU/EEA, 2014 Source: Country reports from Austria, Denmark, Estonia, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Portugal, Romania, Slovakia, Slovenia, and the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Table. Hepatitis C, surveillance systems overview, 2014 Surveillance Data reported by Case definition used characteristics Country Data source L P H O Austria AT-Epidemiegesetz Co C Y EU-2008 Belgium BE-LABNET Se N . Other Bulgaria BG-NATIONAL_SURVEILLANCE Croatia HR-CNIPH A EU-2012 Cyprus CY-NOTIFIED_DISEASES Czech Republic CZ-EPIDAT Denmark DK-MIS Estonia EE-NAKIS Finland FI-NIDR Germany DE-SURVNET@RKI-7.1/6 Greece EL-NOTIFIABLE_DISEASES Hungary HU-EFRIR Iceland IS-SUBJECT_TO_REGISTRATION Ireland IE-CIDR Italy IT-NRS IT-SEIEVA Latvia LV-BSN Lithuania LT-COMMUNICABLE_DISEASES Luxembourg LU-SYSTEM1 Malta MT-DISEASE_SURVEILLANCE Netherlands NL-OSIRIS Norway NO-MSIS_A Poland PL-NATIONAL_SURVEILLANCE Portugal PT-HEPATITISC Romania RO-RNSSy Slovakia SK-EPIS Slovenia SI-SURVIVAL Sweden SE-SMINET United Kingdom UK-HEPATITISC Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Hepatitis C. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged